Invexans Balance Sheet Health
Financial Health criteria checks 4/6
Invexans has a total shareholder equity of $1.6B and total debt of $550.6M, which brings its debt-to-equity ratio to 33.8%. Its total assets and total liabilities are $3.0B and $1.4B respectively. Invexans's EBIT is $86.8M making its interest coverage ratio 2.5. It has cash and short-term investments of $450.4M.
Key information
33.8%
Debt to equity ratio
US$550.60m
Debt
| Interest coverage ratio | 2.5x |
| Cash | US$450.42m |
| Equity | US$1.63b |
| Total liabilities | US$1.40b |
| Total assets | US$3.03b |
Recent financial health updates
Here's Why Invexans (SNSE:INVEXANS) Can Manage Its Debt Responsibly
Oct 30
We Think Invexans (SNSE:INVEXANS) Is Taking Some Risk With Its Debt
May 06Would Invexans (SNSE:INVEXANS) Be Better Off With Less Debt?
Dec 23
Recent updates
Invexans (SNSE:INVEXANS) Is Looking To Continue Growing Its Returns On Capital
Sep 23The Return Trends At Invexans (SNSE:INVEXANS) Look Promising
Apr 29Invexans (SNSE:INVEXANS) Is Doing The Right Things To Multiply Its Share Price
Aug 27Here's Why Invexans (SNSE:INVEXANS) Can Manage Its Debt Responsibly
Oct 30We Think Invexans (SNSE:INVEXANS) Is Taking Some Risk With Its Debt
May 06Invexans (SNSE:INVEXANS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 01Returns On Capital Are Showing Encouraging Signs At Invexans (SNSE:INVEXANS)
Mar 30Introducing Invexans (SNSE:INVEXANS), The Stock That Zoomed 155% In The Last Year
Feb 16Would Invexans (SNSE:INVEXANS) Be Better Off With Less Debt?
Dec 23Financial Position Analysis
Short Term Liabilities: INVEXANS's short term assets ($1.0B) exceed its short term liabilities ($830.5M).
Long Term Liabilities: INVEXANS's short term assets ($1.0B) exceed its long term liabilities ($569.1M).
Debt to Equity History and Analysis
Debt Level: INVEXANS's net debt to equity ratio (6.2%) is considered satisfactory.
Reducing Debt: INVEXANS's debt to equity ratio has increased from 2.1% to 33.8% over the past 5 years.
Debt Coverage: INVEXANS's debt is well covered by operating cash flow (26.4%).
Interest Coverage: INVEXANS's interest payments on its debt are not well covered by EBIT (2.5x coverage).